merck

(MedPage Today) -- The investigational anticoagulant vorapaxar significantly reduced cardiovascular events, but at the expense of intracranial hemorrhage, according to top-line results announced today by drugmaker Merck.

US drugs firm Merck & Co agrees to pay almost $1bn to settle charges arising from the marketing of one of its drugs, Vioxx, the US Department of Justice says.

Merck's anti-clotting drug flops in key trial (AP) — A blood thinner being developed by Merck has flopped in a major study aimed at preventing heart attacks, strokes and other problems in people who had suffered a heart attack or severe chest pain from clogged arteries.

On the Fear and Loathing in Bioethics blog, Carl Elliott noted that Merck, the pharmaceutical manufacturer who brought us the Vioxx scandal, has hired some bioethics advisers.  Let's see what effect they have.

(MedPage Today) -- Once-daily use of the anti-HIV drug raltegravir (Isentress) was less effective than the approved twice-daily dosing, Merck announced.

ORLANDO, Fla. (AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work....

WHITEHOUSE STATION, N.J. (AP) -- Merck says its heart failure treatment rolofylline missed its goals in a trial, failing to improve patient symptoms compared with a placebo....

LONDON (AP) -- German drugmaker Merck Serono is one step closer to releasing the first pill to treat multiple sclerosis, the company said Friday....

TRENTON, N.J. (AP) -- Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug....

TRENTON, N.J. (AP) -- Contaminated children's vaccines and other potentially serious concerns were spotted by federal regulators who combed Merck & Co.'s vaccine plant in the Philadelphia suburbs, according to a published report....